HOME >> BIOLOGY >> NEWS
UCF brain cell research spawns hope for longer life

stents and other devices that are prone to inflammatory reactions.

Initial tests show that the nanoparticle anti-oxidants regenerate once they penetrate the cell -- meaning one dose could conceivably continue its therapeutic effects indefinitely.

Rzigalinski introduced the collaboration to her colleagues at the NATURE biotechnology symposium in Miami earlier this year. She has also submitted an abstract on the project to the National and International Neurotrauma Symposium, and Society for Neuroscience.

Nanotechnology is considered the new frontier of science, and it could revolutionize modern medicine in the future. The potential for creating new materials at a size capable of being absorbed by human cells calls for a new type of scientist -- one who can collaborate across seemingly unrelated disciplines. Combining the fields of biomolecular science with engineering offers a significant step in that direction.

Pappachan Kolattukudy, director of UCF's Biomolecular Science Center and a consultant on the project, said the collaboration is part of a strategy that UCF is going to be using increasingly in building its presence in the biomolecular sciences.

"We are concentrating on building interfaces between areas in which we have strengths," Kolattukudy said.

Vimal Desai, director of AMPAC, said that nanomaterials are currently considered highly strategic for important applications ranging from homeland security to just plain good health.

"It is so good to be able to build bridges for an interdisciplinary effort through competent and dynamic researchers at UCF," Desai said.


'"/>

Contact: Barb Abney
bcompton@mail.ucf.edu
407-823-5139
University of Central Florida
13-Aug-2003


Page: 1 2 3

Related biology news :

1. Trial shows which brain cancer patients benefit from temozolomide
2. Targeted therapy knocks out pediatric brain cancer in mice
3. New way to protect brain from stroke damage
4. Chemical signals health of brain cells Symposium
5. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows
6. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
7. Genetic clues found for common congenital brain disorder
8. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
9. Molecular therapeutics advance fight against brain cancer
10. Depression traced to overactive brain circuit
11. Clusters of alterations on PIK3CA gene found in brain cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/25/2016)... , Jan. 25, 2016   Unisys Corporation (NYSE: ... at John F. Kennedy (JFK) International Airport, New York ... (CBP) identify imposters attempting to enter the United ... belong to them. pilot testing of the system ... at three terminals at JFK during January 2016. --> ...
(Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... FLINT, Mich. , Feb. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that ... as a specialty pharmacy resource–user-centric, story-driven, knowledge-based and mobile-friendly. ... ... ... "The ...
(Date:2/5/2016)...  In the pharmaceutical industry the medical affairs function ... activities including the identification and engagement of key thought ... high in the oncology therapeutic area where most treating ... Role of Medical Affairs in Oncology Launch Excellence ." ... find better ways to utilize medical affairs to develop ...
(Date:2/4/2016)... -- - New FDA action date of July ... date of July 22, 2016   --> ... 2016   - Lifitegrast has the potential ... the treatment of signs and symptoms of dry eye disease in ... be the only product approved in the U.S. in the past decade indicated for the ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016  CytoSorbents ... immunotherapy leader commercializing its flagship CytoSorb® blood filter ... surgery patients around the world, announced that CEO ... present at the Source Capital Group,s 2016 Disruptive ... update on the company.  Conference ...
Breaking Biology Technology:
Cached News: